Management of primary squamous cell carcinoma of the pancreas with a nanosomal paclitaxel lipid suspension-based regimen: A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of primary squamous cell carcinoma of the pancreas with a nanosomal paclitaxel lipid suspension-based regimen: A case report

Published:2019-02-22 Issue: Volume: Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:mol clin onc

Author:

Majumdar Saroj¹,Muduly Dillip²,Mishra Subhasis²,Mohapatra Chinmaya²,Bunger Deepak³,Khan Mujtaba³

Affiliation:

1. Department of Radiotherapy, All India Institute of Medical Sciences, Bhubaneswar, Odisha 751019, India

2. Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha 751019, India

3. Department of Medical Affairs and Clinical Development, Intas Pharmaceuticals Ltd., Ahmedabad, Gujarat 380054, India

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with nanosomal paclitaxel lipid suspension versus conventional paclitaxel in metastatic breast cancer patients – a multicenter, randomized, comparative, phase II/III clinical study;Therapeutic Advances in Medical Oncology;2024-01

2. Unusual-Appearing Hepatic Metastases From the Squamous Cell Carcinoma of the Pancreas;Pancreas;2023-03

3. Partial response in non-resectable adenosquamous carcinoma of the pancreas with high tumour mutation burden treated with gemcitabine, nab-paclitaxel and pembrolizumab;BMJ Case Reports;2023-02

4. Epidemiology, Treatment, and Outcome of Pancreatic Squamous Cell Carcinoma and Pancreatic Adenocarcinoma: A Propensity Score-Matching Analysis Based on SEER-Database;Technology in Cancer Research & Treatment;2022-01

5. Primary Pancreatic Squamous Cell Carcinoma: An Incidental Diagnosis of a Rare Entity;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3